ArticleJournal of translational internal medicine2026
Cirrhotic portal hypertension treated with a 5-hydroxytryptamine receptor 1A antagonist.
Changpeng Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it